---
title: "Genomic Medicine Centres Wave 2"
url: https://alsuprun.com/blog/wave-genetics/genomic-medicine-centres-wave-2-2/
author: "Editorial"
date: 2026-10-02T12:18:23+00:00
categories: ["wave genetics"]
tags: []
---

# Genomic Medicine Centres Wave 2

Whether consumers get their genomic data through medical research, clinical programs or direct-to-consumer services, it’s a new type of information. A big challenge is figuring out how to help them interpret it.

 Extensive surveys and anecdotal evidence show that physicians are apprehensive about this kind of data, partly because electronic medical records were not designed to hold it.

 

## What is a Genomics Medicine Centre?

 Genomic medicine is a new type of healthcare that uses information encoded in our genomes (the complete set of DNA instructions for making a person’s cells and organs) to guide personalized treatment and care. This approach to medicine can reveal the hidden causes of disease, predict risk of future illness, and determine whether a drug will work for a patient before it is prescribed.

 [![Rejuvenate your whole body & balance your health without medications - now remotely!](https://alsuprun.com/blog/wp-content/uploads/BioresonanceTopAd.png)](https://www.bioresonance.rent) A genomic medicine centre is a multidisciplinary team of physicians, scientists and genetic counselors that provides clinical genomic testing, interpretation and education. The centres also conduct research to advance genomic medicine and improve health outcomes.

 A well-functioning genomics platform is a critical step in the transformation of healthcare towards precision medicine. As genomics analysis becomes the standard diagnostic procedure for rare diseases, a system that enables effective clinical integration is needed.

 At Karolinska, the Genomic Medicine Center Karolinska Rare Diseases (GMCK-RD) has established a genomic integration model for clinical diagnostics by bringing together healthcare and academia. In a unique healthcare setting, experienced specialists in the areas of child and adult neurology, metabolic diseases, endocrinology and clinical chemistry collaborate closely with geneticists and scientists specialized in sequencing and bioinformatics.

 [![](https://alsuprun.com/blog/wp-content/uploads/ForeverYoungYouWannaBe.png)](https://alsuprun.com/services.html#Contact) The GMCK-RD approach has led to the identification of more than 1,000 diagnoses for rare diseases, and it has also contributed to medical knowledge by identifying genes and phenotypes that were previously unknown. Its unique healthcare environment is a model for how genome sequencing can be integrated into everyday healthcare, and the centre is currently developing a strategy to move from genomics into precision medicine as part of a long-term systems shift. This will require deep clinical integration across multiple specialties, challenging the current organization of healthcare.

 

## What are the Benefits of a Genomics Medicine Centre?

 The field of genomic medicine represents a groundbreaking advancement in healthcare, integrating DNA into clinical practice to improve diagnostics and optimize treatment strategies. This pioneering approach offers a unique opportunity to tailor medical interventions to the distinct biological profile of each patient, which leads to improved health outcomes.

 Genetic testing can reveal many insights, such as a predisposition to certain diseases, potential drug interactions or adverse reactions, family history of disease, and the ability to predict when an individual will need preventive screening. However, understanding the complexity of these results requires guidance from a genetic counselor, who can provide the information patients need to make informed healthcare decisions.

 Additionally, genomic profiling of cancerous tumors has been shown to enhance treatment options by identifying specific mutations within a patient’s cancer cells. As a result, targeted therapies are often more effective than standard chemotherapy, with higher rates of success and fewer side effects.

 As the demand for genomic medicine grows, it is critical that healthcare professionals are equipped to support this change in clinical practice. To this end, GMCK-RD is developing a range of educational programmes to equip healthcare professionals who do not specialise in genetics with the tools they need to identify and refer patients for genomic testing.

 Furthermore, GMCK-RD is working on the development of targeted patient flows for various disease groups using the model developed for Inherited Enzyme Malformations (IEM). These will enable genomic testing to be integrated into the clinical workflow for these conditions.

 [![](https://alsuprun.com/blog/wp-content/uploads/RadionicMerch.png)](https://alsuprun.com/merch.html) 

## What is the Difference Between a Genomics Medicine Centre and a Traditional Medicine Centre?

 Genomic medicine takes a much broader view of health than traditional medical tests, looking at all your genes together to assess your risk of disease or to explain unexplained symptoms and guide your treatment. It is about personalised care that is matched to you, your lifestyle and the environment you live in.

 Integrating genomics into clinical practice is complex. Clinical specialities operate under tight consultation windows forcing genomic insights to compete with immediate diagnostic and treatment decisions, resulting in low real-world utilization rates even for advanced genetics services piloting clinical decision support for pharmacogenomics or oncology1.

 The development of specialist cancer genomic networks centred around Genomic Laboratory Hubs (GLH) will be essential to ensure that patients from more regions are able to access genomic testing in a safe, structured and linked up fashion to existing pathology and clinical care pathways. These will need to be closely coordinated with frontline clinicians and disease specialists (e.g. cancer, rare diseases) to allow for a seamless and integrated approach.

 It will be necessary to expand and improve the current National Genomic Test Directory (NGTD)6 to enable a wider range of clinical specialists to order and interpret genomic tests. This will require a change in the way that medical tests are ordered across the NHS and will be dependent on the evolution of specialty / disease dependent pathways with clearer definitions of the attributes of seniority, sub-specialty or expertise by which clinical specialties can order particular tests.

 It will also be important to develop and enhance training for non-geneticist clinical staff to facilitate a wider range of healthcare professionals being able to use genetic information in their day to day work. A recent study found that UK practising nurses and midwives had relatively low levels of confidence in using genetic information, highlighting the need to provide appropriate, tailored education for this workforce.

 

## What is the Difference Between a Genomics Medicine Centre and a Personalized Medicine Centre?

 A genomic medicine centre is a place where patients can get the tests they need to make the best health decisions. It’s also where doctors can use the results of those tests to provide more personalized care for their patients. The genome is the blueprint for a person’s DNA, which includes all the instructions needed to grow and develop. It also contains information about how a person’s body works, including the types of diseases they may get and their response to treatment.

 Genomic medicine centres are helping to transform healthcare systems around the world, enabling life-saving advances in cancer care, rare disease diagnosis, and precision therapeutics. The growth of these centres is driven by the availability of next-generation sequencing technologies, expanding clinical application of precision medicines, and increasing demand for personalized treatments.

 However, the full potential of genomic medicine is constrained by the operational challenge of embedding genomic insights into routine clinical decision inputs across large provider systems. Clinicians typically operate under tight consultation windows, which mean genomic insights have to compete with immediate diagnostic and treatment decisions. As a result, real-world utilization of genomics for pharmacogenomics and oncology panels remains below 20 to 30% in many advanced systems.

 Nationally-scale flagship projects such as the 100,000 Genomes Project in the UK are demonstrating how genomic medicine can be scaled. Experience at IPD suggests that pragmatic pilot projects focusing on clearly defined clinical questions provide a pragmatic pathway forward, whilst allowing for learning that supports wider deployment and builds sustainable infrastructure. The successful rollout of genomic medicine will require deliberate workforce development, unified technological platforms, robust data systems and equitable international collaboration. Ultimately, success will be measured by the extent to which genomic medicine is used to improve patient outcomes.

 

## What is the Difference Between a Genomics Medicine Centre and a Precision Medicine Centre?

 A genomic medicine centre is focused on leveraging new technologies to advance precision healthcare (also known as clinical genomics, personalised healthcare, and stratified medicine). It aims to transform patient care through the application of genomic information. It combines DNA sequencing with other medical information such as images or biopsies to provide an accurate and complete picture of the person’s health. It helps to make better decisions about diagnosis, treatment, and prevention.

 The underlying genetic causes of a disease are complex, with many factors impacting the onset and progression of the condition. These include lifestyle and environmental factors as well as the individual’s genes and immune response. A genomic approach aims to identify these key factors and develop more targeted interventions, improving outcomes for people with specific conditions.

 Genomics is already transforming healthcare today. For example, cancer patients can be tested to determine the right treatment for them based on their inherited gene mutations. This can lead to improved outcomes, reduced side effects, and a more tailored approach to treatment.

 However, industry leaders agree that there are still challenges to implementing genomics into mainstream healthcare. They all agreed that more education is needed for healthcare professionals. This includes both training existing healthcare workforces and embedding genomics in undergraduate medical and healthcare training. They also discussed the need for more standardized, clear patient reports that are easy for non-specialists to understand.

 They also highlighted the need to increase diversity in genomics research. As the genomics field develops, it’s important that all groups of people have representation in the research, as this ultimately leads to superior science and better health outcomes for everyone. One of the ways that this is being addressed is through CZI’s Accelerate Precision Health program, which partners with historically black medical schools to help expand access to genomic testing for underrepresented communities.

```json
{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "Genomic Medicine Centres Wave 2",
    "url": "https://alsuprun.com/blog/wave-genetics/genomic-medicine-centres-wave-2-2/",
    "datePublished": "2026-10-02T12:18:23+00:00",
    "dateModified": "2026-10-02T12:18:31+00:00",
    "author": {
        "@type": "Person",
        "name": "Editorial"
    },
    "publisher": {
        "@type": "Organization",
        "name": "Information Wellness Blog",
        "url": "https://alsuprun.com/blog/"
    }
}
```